CS
Candriam SCA Portfolio holdings
AUM
$17.3B
1-Year Return
21.68%
This Quarter Return
+8.48%
1 Year Return
+21.68%
3 Year Return
+102.54%
5 Year Return
+176.54%
10 Year Return
+489.52%
AUM
$14.8B
AUM Growth
+$630M
(+4.4%)
Cap. Flow
-$386M
Cap. Flow
% of AUM
-2.61%
Top 10 Holdings %
Top 10 Hldgs %
24.14%
Holding
926
New
50
Increased
255
Reduced
457
Closed
57
Top Buys
| 1 |
Mercado Libre
MELI
|
+$41.1M |
| 2 |
Darling Ingredients
DAR
|
+$37M |
| 3 |
Johnson & Johnson
JNJ
|
+$34.5M |
| 4 |
Veru
VERU
|
+$34M |
| 5 |
MetLife
MET
|
+$31.5M |
Top Sells
| 1 |
PepsiCo
PEP
|
+$46.7M |
| 2 |
Nike
NKE
|
+$42.5M |
| 3 |
Illinois Tool Works
ITW
|
+$37M |
| 4 |
Gilead Sciences
GILD
|
+$32.3M |
| 5 |
Merck
MRK
|
+$30.3M |
Sector Composition
| 1 | Healthcare | 33.31% |
| 2 | Technology | 22.85% |
| 3 | Financials | 10.04% |
| 4 | Consumer Discretionary | 7.69% |
| 5 | Industrials | 7.6% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
SIVB
701
DELISTED
SVB Financial Group
SIVB
| $854K | 0.01% |
3,709
-16
| -0.4% | -$3.68K |
|
702
Generac Holdings
GNRC
$11.1B
| $853K | 0.01% |
8,479
-946
| -10% | -$95.2K |
|
703
Annexon
ANNX
$268M
| $851K | 0.01% |
164,558
-992
| -0.6% | -$5.13K |
|
704
Brookfield
BN
$103B
| $848K | 0.01% |
26,970
-7,221
| -21% | -$227K |
|
|
NVRO
705
DELISTED
NEVRO CORP.
NVRO
| $843K | 0.01% |
21,278
-224
| -1% | -$8.87K |
|
706
RadNet
RDNT
$5.55B
| $842K | 0.01% |
44,692
-3,172
| -7% | -$59.7K |
|
707
Tandem Diabetes Care
TNDM
$857M
| $835K | 0.01% |
18,587
-23,988
| -56% | -$1.08M |
|
708
Lantheus
LNTH
$3.56B
| $835K | 0.01% |
16,386
+4,109
| +33% | +$209K |
|
|
COWN
709
DELISTED
Cowen Inc. Class A Common Stock
COWN
| $833K | 0.01% |
21,578
| – | – |
|
710
Sun Communities
SUI
$16.2B
| $833K | 0.01% |
5,827
| – | – |
|
711
Cerus
CERS
$240M
| $829K | 0.01% |
227,107
-18,684
| -8% | -$68.2K |
|
|
KNTE
712
DELISTED
Kinnate Biopharma Inc. Common Stock
KNTE
| $825K | 0.01% |
135,298
+68,941
| +104% | +$421K |
|
713
Owens & Minor
OMI
$411M
| $825K | 0.01% |
42,252
+2,652
| +7% | +$51.8K |
|
714
Opko Health
OPK
$1.13B
| $818K | 0.01% |
654,601
+202,253
| +45% | +$253K |
|
|
NARI
715
DELISTED
Inari Medical, Inc. Common Stock
NARI
| $814K | 0.01% |
12,809
-1,625
| -11% | -$103K |
|
716
Carlisle Companies
CSL
$16.6B
| $804K | 0.01% |
+3,414
| New | +$804K |
|
717
FMC
FMC
$4.68B
| $789K | 0.01% |
6,323
-2,635
| -29% | -$329K |
|
718
AdaptHealth
AHCO
$1.26B
| $787K | 0.01% |
40,931
-13,876
| -25% | -$267K |
|
|
LSXMK
719
DELISTED
Liberty Media Corporation Series C Liberty SiriusXM Common Stock
LSXMK
| $784K | 0.01% |
25,879
-12,297
| -32% | -$373K |
|
720
Telus
TU
$24.2B
| $771K | 0.01% |
39,956
-5,751
| -13% | -$111K |
|
721
AMN Healthcare
AMN
$738M
| $770K | 0.01% |
7,492
-2,045
| -21% | -$210K |
|
|
TVRD
722
Tvardi Therapeutics, Inc. Common Stock
TVRD
$309M
| $769K | 0.01% |
1,990
-525
| -21% | -$203K |
|
723
Molson Coors Class B
TAP
$9.73B
| $747K | 0.01% |
14,509
| – | – |
|
724
Unity
U
$18.9B
| $747K | 0.01% |
26,124
-4,149
| -14% | -$119K |
|
725
Zoom
ZM
$24.9B
| $744K | 0.01% |
+10,981
| New | +$744K |
|